KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 134 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 5.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $286,408 | -82.8% | 160,004 | -67.3% | 0.00% | -80.0% |
Q4 2022 | $1,666,034 | +245.7% | 490,010 | +454.5% | 0.01% | +233.3% |
Q3 2022 | $482,000 | -43.9% | 88,364 | -53.6% | 0.00% | -40.0% |
Q2 2022 | $859,000 | -27.8% | 190,479 | +18.0% | 0.01% | -50.0% |
Q1 2022 | $1,190,000 | -67.2% | 161,483 | -71.3% | 0.01% | -70.6% |
Q4 2021 | $3,623,000 | +548.1% | 563,530 | +487.0% | 0.03% | +385.7% |
Q3 2021 | $559,000 | +15.3% | 95,994 | +104.2% | 0.01% | +40.0% |
Q2 2021 | $485,000 | +54.0% | 47,013 | +56.8% | 0.01% | +25.0% |
Q1 2021 | $315,000 | -75.4% | 29,982 | -65.8% | 0.00% | -78.9% |
Q3 2020 | $1,278,000 | +43.1% | 87,543 | +85.7% | 0.02% | +26.7% |
Q2 2020 | $893,000 | +128.4% | 47,153 | +131.5% | 0.02% | +36.4% |
Q1 2020 | $391,000 | -69.4% | 20,366 | -69.4% | 0.01% | -52.2% |
Q4 2019 | $1,277,000 | +152.4% | 66,600 | -21.2% | 0.02% | +155.6% |
Q2 2019 | $506,000 | +381.9% | 84,504 | +372.1% | 0.01% | +200.0% |
Q1 2019 | $105,000 | -69.9% | 17,901 | -51.9% | 0.00% | -81.2% |
Q4 2018 | $349,000 | +2.6% | 37,230 | +86.6% | 0.02% | -15.8% |
Q3 2018 | $340,000 | +131.3% | 19,949 | +130.4% | 0.02% | +171.4% |
Q2 2018 | $147,000 | -56.9% | 8,659 | -65.9% | 0.01% | -65.0% |
Q1 2018 | $341,000 | +3688.9% | 25,385 | +2536.0% | 0.02% | – |
Q4 2017 | $9,000 | – | 963 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |